These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


177 related items for PubMed ID: 12445678

  • 21. Baicalin is a major component of PC-SPES which inhibits the proliferation of human cancer cells via apoptosis and cell cycle arrest.
    Ikezoe T, Chen SS, Heber D, Taguchi H, Koeffler HP.
    Prostate; 2001 Dec 01; 49(4):285-92. PubMed ID: 11746275
    [Abstract] [Full Text] [Related]

  • 22. Mesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpression.
    Bharadwaj U, Marin-Muller C, Li M, Chen C, Yao Q.
    Mol Cancer; 2011 Aug 31; 10():106. PubMed ID: 21880146
    [Abstract] [Full Text] [Related]

  • 23. [In vitro evaluation of potentially effective gemcitabine combination therapy for exocrine pancreatic carcinoma].
    Kreil A, Bauer J, Scheithauer W.
    Acta Med Austriaca; 1999 Aug 31; 26(3):93-100. PubMed ID: 10520377
    [Abstract] [Full Text] [Related]

  • 24. PC-SPES decreases proliferation and induces differentiation and apoptosis of human acute myeloid leukemia cells.
    Ikezoe T, Chen S, Saito T, Asou H, Kyo T, Tanosaki S, Heber D, Taguchi H, Koeffler HP.
    Int J Oncol; 2003 Oct 31; 23(4):1203-11. PubMed ID: 12964005
    [Abstract] [Full Text] [Related]

  • 25. PC-SPES inhibits cell proliferation by modulating p21, cyclins D, E and B and multiple cell cycle-related genes in prostate cancer cells.
    Lu X, Guo J, Hsieh TC.
    Cell Cycle; 2003 Oct 31; 2(1):59-63. PubMed ID: 12695690
    [Abstract] [Full Text] [Related]

  • 26. [Effect of compound Chinese traditional medicine PC-SPES II in inhibiting proliferation of human prostate cancer cell LNCaP and on expressions of AR and PSA].
    Zhang BY, Li YF, Lai Y, Li YS, Chen ZJ.
    Zhongguo Zhong Yao Za Zhi; 2015 Mar 31; 40(5):950-6. PubMed ID: 26087562
    [Abstract] [Full Text] [Related]

  • 27. Induction of apoptosis and down-regulation of bcl-6 in mutu I cells treated with ethanolic extracts of the Chinese herbal supplement PC-SPES.
    Hsieh TC, Ng C, Chang CC, Chen SS, Mittleman A, Wu JM.
    Int J Oncol; 1998 Dec 31; 13(6):1199-202. PubMed ID: 9824631
    [Abstract] [Full Text] [Related]

  • 28. Comparison of the effects of photon versus carbon ion irradiation when combined with chemotherapy in vitro.
    Schlaich F, Brons S, Haberer T, Debus J, Combs SE, Weber KJ.
    Radiat Oncol; 2013 Nov 06; 8():260. PubMed ID: 24192264
    [Abstract] [Full Text] [Related]

  • 29. Anti-tumor effects of PC-SPES, an herbal formulation in prostate cancer.
    Tiwari RK, Geliebter J, Garikapaty VP, Yedavelli SP, Chen S, Mittelman A.
    Int J Oncol; 1999 Apr 06; 14(4):713-9. PubMed ID: 10087319
    [Abstract] [Full Text] [Related]

  • 30. Additive growth inhibition after combined treatment of 2-methoxyestradiol and conventional chemotherapeutic agents in human pancreatic cancer cells.
    Fotopoulou C, Baumunk D, Schmidt SC, Schumacher G.
    Anticancer Res; 2010 Nov 06; 30(11):4619-24. PubMed ID: 21115915
    [Abstract] [Full Text] [Related]

  • 31. Chinese herbal mixture PC SPES in treatment of prostate cancer (review).
    Darzynkiewicz Z, Traganos F, Wu JM, Chen S.
    Int J Oncol; 2000 Oct 06; 17(4):729-36. PubMed ID: 10995884
    [Abstract] [Full Text] [Related]

  • 32. Herbal composition PC-SPES for management of prostate cancer: identification of active principles.
    Sovak M, Seligson AL, Konas M, Hajduch M, Dolezal M, Machala M, Nagourney R.
    J Natl Cancer Inst; 2002 Sep 04; 94(17):1275-81. PubMed ID: 12208892
    [Abstract] [Full Text] [Related]

  • 33. Inhibition of pancreatic cancer and potentiation of gemcitabine effects by the extract of Pao Pereira.
    Yu J, Drisko J, Chen Q.
    Oncol Rep; 2013 Jul 04; 30(1):149-56. PubMed ID: 23674070
    [Abstract] [Full Text] [Related]

  • 34. Interferon-beta enhances sensitivity to gemcitabine in pancreatic cancer.
    Blaauboer A, Booy S, van Koetsveld PM, Karels B, Dogan F, van Zwienen S, van Eijck CHJ, Hofland LJ.
    BMC Cancer; 2020 Sep 23; 20(1):913. PubMed ID: 32967656
    [Abstract] [Full Text] [Related]

  • 35. HS-104, a PI3K inhibitor, enhances the anticancer efficacy of gemcitabine in pancreatic cancer.
    Jung KH, Yan HH, Fang Z, Son MK, Lee H, Hong S, Hong SS.
    Int J Oncol; 2014 Jul 23; 45(1):311-21. PubMed ID: 24819705
    [Abstract] [Full Text] [Related]

  • 36. Irisin Enhances Doxorubicin-Induced Cell Apoptosis in Pancreatic Cancer by Inhibiting the PI3K/AKT/NF-κB Pathway.
    Liu J, Huang Y, Liu Y, Chen Y.
    Med Sci Monit; 2019 Aug 14; 25():6085-6096. PubMed ID: 31412018
    [Abstract] [Full Text] [Related]

  • 37. Synergistic effects of baicalein with gemcitabine or docetaxel on the proliferation, migration and apoptosis of pancreatic cancer cells.
    Liu P, Feng J, Sun M, Yuan W, Xiao R, Xiong J, Huang X, Xiong M, Chen W, Yu X, Sun Q, Zhao X, Zhang Q, Shao L.
    Int J Oncol; 2017 Dec 14; 51(6):1878-1886. PubMed ID: 29039524
    [Abstract] [Full Text] [Related]

  • 38. Molecular effects of the herbal compound PC-SPES: identification of activity pathways in prostate carcinoma.
    Bonham M, Arnold H, Montgomery B, Nelson PS.
    Cancer Res; 2002 Jul 15; 62(14):3920-4. PubMed ID: 12124319
    [Abstract] [Full Text] [Related]

  • 39. Antitumor activity and combined inhibitory effect of ceritinib with gemcitabine in pancreatic cancer.
    Jamshed MB, Munir F, Shahid N, Sadiq U, Muhammad SA, Ghanem NB, Zhong H, Li X, Zhang Q.
    Am J Physiol Gastrointest Liver Physiol; 2020 Jan 01; 318(1):G109-G119. PubMed ID: 31736340
    [Abstract] [Full Text] [Related]

  • 40. Synergistic cytotoxicity and pharmacogenetics of gemcitabine and pemetrexed combination in pancreatic cancer cell lines.
    Giovannetti E, Mey V, Danesi R, Mosca I, Del Tacca M.
    Clin Cancer Res; 2004 May 01; 10(9):2936-43. PubMed ID: 15131028
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 9.